IL161710A0 - Macrolides - Google Patents

Macrolides

Info

Publication number
IL161710A0
IL161710A0 IL16171002A IL16171002A IL161710A0 IL 161710 A0 IL161710 A0 IL 161710A0 IL 16171002 A IL16171002 A IL 16171002A IL 16171002 A IL16171002 A IL 16171002A IL 161710 A0 IL161710 A0 IL 161710A0
Authority
IL
Israel
Prior art keywords
macrolides
Prior art date
Application number
IL16171002A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Publication of IL161710A0 publication Critical patent/IL161710A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
IL16171002A 2001-11-14 2002-11-13 Macrolides IL161710A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127349.9A GB0127349D0 (en) 2001-11-14 2001-11-14 Macrolides
PCT/GB2002/005101 WO2003042228A1 (en) 2001-11-14 2002-11-13 Macrolides

Publications (1)

Publication Number Publication Date
IL161710A0 true IL161710A0 (en) 2004-09-27

Family

ID=9925777

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16171002A IL161710A0 (en) 2001-11-14 2002-11-13 Macrolides

Country Status (20)

Country Link
US (1) US7202221B2 (ja)
EP (1) EP1453846B1 (ja)
JP (1) JP2005515978A (ja)
CN (1) CN1307194C (ja)
AR (1) AR037371A1 (ja)
AT (1) ATE362479T1 (ja)
BR (1) BR0214132A (ja)
CA (1) CA2466975A1 (ja)
DE (1) DE60220180T2 (ja)
EA (1) EA007433B1 (ja)
ES (1) ES2287332T3 (ja)
GB (1) GB0127349D0 (ja)
HR (1) HRP20040433A2 (ja)
HU (1) HUP0402225A3 (ja)
IL (1) IL161710A0 (ja)
PL (1) PL371472A1 (ja)
RS (1) RS41904A (ja)
UA (1) UA77210C2 (ja)
WO (1) WO2003042228A1 (ja)
ZA (1) ZA200403684B (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
ES2319176T3 (es) * 2002-05-14 2009-05-05 The Regents Of The University Of California Acidos quinolona-carboxilicos sustituidos, sus derivados, sitio de accion y uso de los mismos.
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
ES2278319T3 (es) * 2003-05-13 2007-08-01 Glaxo Group Limited Nuevos compuestos con 14 y 15 miembros en el anillo.
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310986D0 (en) 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
JP2007536372A (ja) * 2004-05-06 2007-12-13 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 微生物感染症の治療に有用なカルバミン酸エステル結合マクロライド
WO2005108412A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ester linked macrolides useful for the treatment of microbial infections
WO2006047167A2 (en) * 2004-10-21 2006-05-04 Janssen Pharmaceutica, N.V. 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424959D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424951D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
CN101511855B (zh) * 2006-08-09 2013-04-24 巴斯利尔药物股份公司 用于抗炎性和过敏性疾病的大环内酯类
CA2661538A1 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
CA2713776C (en) 2008-02-08 2018-06-05 Basilea Pharmaceutica Ag Macrolides as pde4 inhibitors
AU2010252641B2 (en) 2009-05-27 2015-09-17 Wockhardt Research Centre Ketolide compounds having antimicrobial activity
DK2673285T3 (en) 2010-12-09 2017-10-16 Wockhardt Ltd Ketolide compounds
BR112013019283A2 (pt) * 2011-01-31 2016-09-13 Meiji Seika Pharma Co Ltd composto, fármaco, composição farmacêutica e uso
CN103619849B (zh) 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
EP0465581B1 (en) * 1989-03-28 1995-10-04 Abbott Laboratories Erythromycin derivatives
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
NZ332320A (en) 1996-05-07 2000-07-28 Abbott Lab 6-0-substituted erythromycin compounds and medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US6262030B1 (en) * 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
ES2256030T3 (es) 1999-08-24 2006-07-16 Abbott Laboratories 9a-azalidas con actividad antibacteriana.
EP1259923B1 (en) 2000-02-24 2005-12-14 Abbott Laboratories Anti-infective agents useful against mulitidrug-resistant strains of bacteria
US6946446B2 (en) * 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
US7202221B2 (en) 2007-04-10
HUP0402225A3 (en) 2006-01-30
AR037371A1 (es) 2004-11-03
UA77210C2 (en) 2006-11-15
GB0127349D0 (en) 2002-01-02
WO2003042228A1 (en) 2003-05-22
US20050080025A1 (en) 2005-04-14
CA2466975A1 (en) 2003-05-22
ZA200403684B (en) 2005-09-13
DE60220180T2 (de) 2008-01-17
HRP20040433A2 (en) 2005-04-30
EP1453846A1 (en) 2004-09-08
EA200400536A1 (ru) 2004-12-30
DE60220180D1 (de) 2007-06-28
RS41904A (en) 2006-10-27
EA007433B1 (ru) 2006-10-27
HUP0402225A2 (hu) 2005-02-28
ES2287332T3 (es) 2007-12-16
ATE362479T1 (de) 2007-06-15
BR0214132A (pt) 2004-09-14
JP2005515978A (ja) 2005-06-02
CN1307194C (zh) 2007-03-28
EP1453846B1 (en) 2007-05-16
CN1612888A (zh) 2005-05-04
PL371472A1 (en) 2005-06-13

Similar Documents

Publication Publication Date Title
GB0127349D0 (en) Macrolides
DE60213216D1 (en) Metalloproteinaseinhibitoren
IL157974A0 (en) Pesticidal macrolides
AU2002360430A8 (en) 14-methyl-epothilones
HU0400176V0 (en) Improved gasketseal
GB0108534D0 (en) Retaining means
AU2002313943A8 (en) Electromobile
GB0108110D0 (en) Keeps
GB0127351D0 (en) Macrolides
GB0127345D0 (en) Macrolides
GB0126277D0 (en) Macrolides
GB0127369D0 (en) Macrolides
GB0127352D0 (en) Macrolides
GB2376939B (en) Retaining means
AU2001100134A4 (en) Enviro-trap
GB0031309D0 (en) Macrolides
GB0025691D0 (en) Macrolides
GB0025687D0 (en) Macrolides
GB0025689D0 (en) Macrolides
GB0031314D0 (en) Macrolides
GB0031313D0 (en) Macrolides
GB0031311D0 (en) Macrolides
GB0031306D0 (en) Macrolides
GB0025685D0 (en) Macrolides
GB0025683D0 (en) Macrolides